CD38-SADA:177Lu-DOTA Drug Complex
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD38-SADA:177Lu-DOTA Drug Complex, covering 2026-03-12 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1, Open-label, Dose-escalation Trial With CD38-SADA:177 Lu-DOTA Drug Complex in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 1]